US Stock MarketDetailed Quotes
APDN Applied DNA Sciences
- 0.182
- -0.007-3.71%
Close Oct 31 16:00 ET
- 0.180
- -0.002-0.88%
Pre 05:06 ET
1.87MMarket Cap-24P/E (TTM)
0.189High0.172Low5.83MVolume0.186Open0.189Pre Close1.05MTurnover62.84%Turnover RatioLossP/E (Static)10.30MShares22.80052wk High0.15P/B1.69MFloat Cap0.17252wk Low--Dividend TTM9.29MShs Float719999.520Historical High--Div YieldTTM8.75%Amplitude0.172Historical Low0.180Avg Price1Lot Size
Applied DNA Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -72.66%797.52K | -78.91%929.63K | -83.07%891.16K | -26.43%13.37M | -78.09%779.74K | -32.10%2.92M | -28.30%4.41M | 26.34%5.26M | 101.25%18.17M | 17.09%3.56M |
| Operating revenue | -72.66%797.52K | -78.91%929.63K | -83.07%891.16K | -26.43%13.37M | -78.09%779.74K | -32.10%2.92M | -28.30%4.41M | 26.34%5.26M | 101.25%18.17M | 17.09%3.56M |
| Cost of revenue | -66.49%552.29K | -75.62%633.98K | -77.12%660.07K | -40.27%7.83M | -77.70%700.74K | -49.40%1.65M | -28.93%2.6M | -5.61%2.89M | 188.57%13.12M | 59.33%3.14M |
| Gross profit | -80.68%245.23K | -83.64%295.65K | -90.28%231.1K | 9.49%5.53M | -81.05%79K | 22.14%1.27M | -27.37%1.81M | 114.37%2.38M | 12.73%5.05M | -60.95%416.76K |
| Operating expense | -13.00%3.59M | -13.26%3.91M | 11.77%4.02M | -13.33%16.49M | -8.98%4.25M | 5.97%4.13M | -2.83%4.51M | -38.16%3.6M | 11.84%19.02M | -2.70%4.67M |
| Selling and administrative expenses | -18.63%2.68M | -14.83%3M | 17.48%3.08M | -15.54%12.75M | -11.85%3.31M | 8.55%3.29M | -1.40%3.52M | -44.56%2.63M | 17.53%15.1M | 7.45%3.76M |
| Research and development costs | 9.20%913.03K | -7.64%913.19K | -3.65%935.82K | -4.86%3.74M | 2.85%938.91K | -3.12%836.12K | -7.60%988.74K | -10.07%971.3K | -5.72%3.93M | -29.93%912.88K |
| Operating profit | -17.05%-3.35M | -33.79%-3.62M | -210.84%-3.79M | 21.59%-10.95M | 1.92%-4.17M | -0.09%-2.86M | -25.52%-2.7M | 74.10%-1.22M | -11.52%-13.97M | -13.97%-4.25M |
| Net non-operating interest income expense | 35.52%36.3K | 321.87%15.35K | 804.04%33.32K | 946.28%75.33K | 2,872.17%41.22K | 26.78K | -34.31%3.64K | 1,250.18%3.69K | -47.35%7.2K | -18.41%1.39K |
| Non-operating interest income | 35.52%36.3K | 321.87%15.35K | 804.04%33.32K | 946.28%75.33K | 2,872.17%41.22K | --26.78K | -34.31%3.64K | 1,250.18%3.69K | -47.35%7.2K | -18.41%1.39K |
| Other net income (expense) | 1,930.60%5.16M | -127.41%-891.38K | 199.87%2.63M | -84.98%855.04K | -85.67%513.95K | -116.28%-281.87K | 736.09%3.25M | -17,897.91%-2.63M | 422.48%5.69M | 560.89%3.59M |
| Gain on sale of security | 1,953.45%5.16M | -108.08%-262.77K | 200.05%2.64M | -88.47%854.4K | -89.32%519.7K | -115.83%-278.4K | 315.45%3.25M | ---2.64M | --7.41M | --4.87M |
| Special income (charges) | --0 | ---633.2K | ---- | --0 | --0 | --0 | --0 | ---- | 5.03%-1.67M | -55.37%-1.28M |
| -Less：Restructuring and merger&acquisition | --0 | --633.2K | ---- | --0 | --0 | --0 | --0 | ---- | --1.67M | --1.28M |
| Other non- operating income (expenses) | 97.09%-101 | 593.04%4.58K | -253.04%-13.54K | 101.36%642 | -41.06%-5.75K | 86.84%-3.47K | 129.17%661 | 160.56%8.85K | -440.26%-47.31K | -109.36%-4.08K |
| Income before tax | 159.39%1.85M | -915.31%-4.49M | 70.60%-1.13M | -21.20%-10.02M | -444.07%-3.62M | -176.87%-3.11M | 131.32%551.18K | 18.57%-3.84M | 42.08%-8.27M | 85.26%-664.55K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 159.39%1.85M | -915.31%-4.49M | 70.60%-1.13M | -21.20%-10.02M | -444.07%-3.62M | -176.87%-3.11M | 131.32%551.18K | 18.57%-3.84M | 42.08%-8.27M | 85.26%-664.55K |
| Net income continuous Operations | 159.39%1.85M | -915.31%-4.49M | 70.60%-1.13M | -21.20%-10.02M | -444.07%-3.62M | -176.87%-3.11M | 131.32%551.18K | 18.57%-3.84M | 42.08%-8.27M | 85.26%-664.55K |
| Minority interest income | -109.96%-30.3K | 37.29%-23.31K | -2,781.12%-25.18K | -3,398.94%-75.86K | -1,651.84%-23.39K | -2,405.03%-14.43K | -3,242.36%-37.17K | -202.22%-874 | -127.09%-2.17K | -138.05%-1.34K |
| Net income attributable to the parent company | 160.64%1.88M | -859.84%-4.47M | 71.25%-1.11M | -20.31%-9.95M | -441.64%-3.59M | -175.73%-3.1M | 133.45%588.34K | 18.60%-3.84M | 42.13%-8.27M | 85.30%-663.22K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 155.33K | 77.76K | 0 | 0 | 0 | 0 | 0 | 110.11K | 0 |
| Net income attributable to common stockholders | 160.64%1.88M | -886.24%-4.63M | 69.22%-1.18M | -18.73%-9.95M | -441.64%-3.59M | -175.73%-3.1M | 131.48%588.34K | 18.60%-3.84M | 41.36%-8.38M | 85.30%-663.22K |
| Basic earnings per share | 109.79%0.47 | -683.52%-5.31 | 70.00%-1.8 | 18.28%-15.2 | -2,775.00%-5.35 | -84.62%-4.8 | 119.78%0.91 | 52.38%-6 | 55.07%-18.6 | 101.61%0.2 |
| Diluted earnings per share | 109.79%0.47 | -683.52%-5.31 | 70.00%-1.8 | 18.28%-15.2 | -2,775.00%-5.35 | -84.62%-4.8 | 119.78%0.91 | 52.38%-6 | 55.07%-18.6 | 101.61%0.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
